IFM Investors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.49M | Buy |
19,835
+1,453
| +8% | +$183K | 0.02% | 477 |
|
|
2025
Q1 | $2.03M | Sell |
18,382
-608
| -3% | -$67.2K | 0.02% | 502 |
|
|
2024
Q4 | $2.59M | Sell |
18,990
-469
| -2% | -$64K | 0.03% | 478 |
|
|
2024
Q3 | $2.24M | Hold |
19,459
| – | – | 0.02% | 516 |
|
|
2024
Q2 | $2.68M | Buy |
19,459
+782
| +4% | +$108K | 0.03% | 475 |
|
|
2024
Q1 | $2.58M | Buy |
18,677
+444
| +2% | +$61.2K | 0.03% | 481 |
|
|
2023
Q4 | $2.4M | Hold |
18,233
| – | – | 0.03% | 456 |
|
|
2023
Q3 | $2.05M | Buy |
18,233
+511
| +3% | +$57.5K | 0.03% | 501 |
|
|
2023
Q2 | $1.67M | Sell |
17,722
-14
| -0.1% | -$1.32K | 0.02% | 539 |
|
|
2023
Q1 | $1.8M | Buy |
17,736
+1,400
| +9% | +$142K | 0.03% | 509 |
|
|
2022
Q4 | $1.95M | Sell |
16,336
-1,246
| -7% | -$149K | 0.03% | 467 |
|
|
2022
Q3 | $1.87M | Sell |
17,582
-239
| -1% | -$25.4K | 0.03% | 463 |
|
|
2022
Q2 | $1.74M | Sell |
17,821
-262
| -1% | -$25.5K | 0.03% | 494 |
|
|
2022
Q1 | $1.7M | Buy |
18,083
+2,466
| +16% | +$231K | 0.03% | 510 |
|
|
2021
Q4 | $1.33M | Buy |
15,617
+903
| +6% | +$76.9K | 0.02% | 546 |
|
|
2021
Q3 | $1.41M | Buy |
14,714
+741
| +5% | +$71.1K | 0.03% | 518 |
|
|
2021
Q2 | $1.36M | Buy |
13,973
+3,877
| +38% | +$377K | 0.03% | 550 |
|
|
2021
Q1 | $982K | Buy |
10,096
+1,292
| +15% | +$126K | 0.03% | 546 |
|
|
2020
Q4 | $844K | Buy |
8,804
+1,577
| +22% | +$151K | 0.03% | 537 |
|
|
2020
Q3 | $695K | Buy |
7,227
+708
| +11% | +$68.1K | 0.03% | 492 |
|
|
2020
Q2 | $795K | Sell |
6,519
-900
| -12% | -$110K | 0.04% | 410 |
|
|
2020
Q1 | $680K | Sell |
7,419
-34
| -0.5% | -$3.12K | 0.03% | 474 |
|
|
2019
Q4 | $801K | Buy |
+7,453
| New | +$801K | 0.03% | 527 |
|